+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gilead Sciences Inc - logo

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

Viral Vectors and Plasmid DNA Manufacturing Market (2nd Edition), 2018-2030 - Product Thumbnail Image

Viral Vectors and Plasmid DNA Manufacturing Market (2nd Edition), 2018-2030

  • Report
  • April 2018
  • 449 Pages
  • Global
From
Specialty Pharmaceuticals Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

Specialty Pharmaceuticals Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • August 2022
  • 110 Pages
  • Global
From
The Corporate Reputation of Pharma in 2021- The Patient Perspective - Germany Edition - The Views of 151 German Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021- The Patient Perspective - Germany Edition - The Views of 151 German Patient Groups

  • Report
  • August 2022
  • 59 Pages
  • Germany
The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Asia Edition - The Views of 300 Asian Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Asia Edition - The Views of 300 Asian Patient Groups

  • Report
  • August 2022
  • 58 Pages
  • Asia Pacific
The Corporate Reputation of Pharma in 2021- The Patient Perspective - France Edition - The Views of 109 French Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021- The Patient Perspective - France Edition - The Views of 109 French Patient Groups

  • Report
  • July 2022
  • 60 Pages
  • France
SARS-CoV-2 Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type - Product Thumbnail Image

SARS-CoV-2 Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type

  • Report
  • February 2024
  • 78 Pages
  • Global
From
Orphan Drugs Global Market Report 2024 - Product Thumbnail Image

Orphan Drugs Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
The Corporate Reputation of Pharma in 2021 - The Patient Perspective - HIV/AIDS Edition -The Views of 168 HIV/AIDS Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021 - The Patient Perspective - HIV/AIDS Edition -The Views of 168 HIV/AIDS Patient Groups

  • Report
  • June 2022
  • 91 Pages
  • Global
Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) - Global Clinical Trials Review, 2023 - Product Thumbnail Image

Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) - Global Clinical Trials Review, 2023

  • Clinical Trials
  • December 2023
  • 545 Pages
  • Global
From
Hepatitis B - Global Clinical Trials Review, 2023 - Product Thumbnail Image

Hepatitis B - Global Clinical Trials Review, 2023

  • Clinical Trials
  • December 2023
  • 1655 Pages
  • Global
From
Antifungal Drugs Market 2020-2024 - Product Thumbnail Image

Antifungal Drugs Market 2020-2024

  • Report
  • November 2020
  • 120 Pages
  • Global
From
Pharmacovigilance Global Market Report 2024 - Product Thumbnail Image

Pharmacovigilance Global Market Report 2024

  • Report
  • February 2024
  • 200 Pages
  • Global
From
Artificial Intelligence (AI) in Drug Discovery Global Market Report 2024 - Product Thumbnail Image

Artificial Intelligence (AI) in Drug Discovery Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Small Molecule Drug Discovery Global Market Report 2024 - Product Thumbnail Image

Small Molecule Drug Discovery Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Drug Formulation Global Market Report 2024 - Product Thumbnail Image

Drug Formulation Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Cutaneous Lupus Erythematosus Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update - Product Thumbnail Image

Cutaneous Lupus Erythematosus Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

  • Report
  • September 2023
  • 111 Pages
  • Global
From
Pharmacovigilance Global Market Opportunities and Strategies to 2032 - Product Thumbnail Image

Pharmacovigilance Global Market Opportunities and Strategies to 2032

  • Report
  • November 2023
  • 305 Pages
  • Global
From
Europe Oral Antiviral Market Size, Share & Industry Trends Analysis Report By Indication (Human Immunodeficiency Virus (HIV), Hepatitis, Influenza), By Drug Class, By Distribution Channel, By Country and Growth Forecast, 2023 - 2029 - Product Thumbnail Image

Europe Oral Antiviral Market Size, Share & Industry Trends Analysis Report By Indication (Human Immunodeficiency Virus (HIV), Hepatitis, Influenza), By Drug Class, By Distribution Channel, By Country and Growth Forecast, 2023 - 2029

  • Report
  • May 2023
  • 93 Pages
  • Europe
From
LAMEA Oral Antiviral Market Size, Share & Industry Trends Analysis Report By Indication (Human Immunodeficiency Virus (HIV), Hepatitis, Influenza), By Drug Class, By Distribution Channel, By Country and Growth Forecast, 2023 - 2029 - Product Thumbnail Image

LAMEA Oral Antiviral Market Size, Share & Industry Trends Analysis Report By Indication (Human Immunodeficiency Virus (HIV), Hepatitis, Influenza), By Drug Class, By Distribution Channel, By Country and Growth Forecast, 2023 - 2029

  • Report
  • May 2023
  • 93 Pages
  • Middle East, Africa
From
North America Oral Antiviral Market Size, Share & Industry Trends Analysis Report By Indication (Human Immunodeficiency Virus (HIV), Hepatitis, Influenza), By Drug Class, By Distribution Channel, By Country and Growth Forecast, 2023 - 2029 - Product Thumbnail Image

North America Oral Antiviral Market Size, Share & Industry Trends Analysis Report By Indication (Human Immunodeficiency Virus (HIV), Hepatitis, Influenza), By Drug Class, By Distribution Channel, By Country and Growth Forecast, 2023 - 2029

  • Report
  • May 2023
  • 83 Pages
  • North America
From
Loading Indicator